 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
UP FRONT
Chief Medical Editor's Page
The Emergence of Renal Artery Stenting
By Barry T. Katzen, MD, Chief Medical Editor
VESSEL UPDATE
Popliteal Artery Aneurysms
There is an increasing role of endovascular therapy for the management
of popliteal artery aneurysmal disease.
By Li Sheng Kong, MD; Karthikeshwar Kasirajan, MD; and Ross Milner, MD
Overview of Carotid and Cerebrovascular Disease
Carotid endarterectomy has been the gold standard for the treatment of carotid disease, but recent data suggest that carotid stenting with embolic protection is a viable alternative.
By Jay S. Yadav, MD
IMAGING & DIAGNOSTICS
Flat Panel Technology
St. Luke’s Hospitals’ clinical experience during the first 1,000
procedures using the Innova 4100.
By Hal Folander, MD, and Renee Martino, RN, CRN
CHALLENGING CASES
Long Segment Disease
The combination of several new technologies for treating the SFA allowed for the treatment of a 6-year-old chronic total occlusion measuring 20 cm.
By Robert M. Bersin, MD
COVER STORY
The Importance of Renal Artery Stenting in Ischemic Nephropathy
Ischemic nephropathy is the most important indication
for intervention in renal artery occlusive disease.
By Thomas A. Sos, MD, and David W. Trost, MD
Tips and Tricks of RAS for High-Risk Patients
Before treating renovascular hypertension or ischemic nephropathy, there are a few things you should know.
By Thomas A. Sos, MD, and David W. Trost, MD
Renal Artery Disease: Facts and Myths
Before developing an appropriate strategy for evaluating and treating RAS, you should understand the sound beliefs and common misconceptions surrounding it.
By Christopher J. White, MD
Embolic Protection Devices in RAS
The use of a distal embolic protection device can significantly improve results after
stent revascularization for patients with ischemic nephropathy.
By Andrew Holden, MBCHB, FRANZCR
Communicating the Benefits of Renal Artery Stenting
The safe and effective treatment of renovascular patients begins with educating everyone involved in the process of referral.
By Andrew B. Covit, MD, and Larry E. Shindelman, MD
DEPARTMENTS
FDA Insights: Top 10 Issues and Insights for Endovascular Grafts
Perspectives on the current state of endovascular grafting technology.
By Dorothy B. Abel
Maximizing the Value of Your Partnership
What should you be doing to prepare your partnership for the new year?
By Michael P. Hatch, CFP, JD
Today's Practice: AdvaMed Alters Industry Interaction
A new code of ethics goes into effect on January 1, 2004.
By Craig McChesney, Publisher
Highlights of AdvaMed’s Revised Code of Ethics
An Interview With Rodney White, MD
One of the world’s foremost endovascular device experts discusses the reasons for the remarkable success of a relatively new technology and the promise it holds.